InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: opportunityknocking post# 19298

Sunday, 05/17/2009 12:54:31 PM

Sunday, May 17, 2009 12:54:31 PM

Post# of 30387
Opportunity stated: "Did you know that Goshen was working on a rapid saliva test before they published their preliminary results?"

It is not a rapid test. Moro used a modified chemiluminescence assay .

Now, read the rules again. You cannot use company material, press releases, publications or other company material to support an attempt to validate the usefulness of RECAF.

All you need to do is produce one independent statement from a reputable source stating there is a huge need for RECAF. Also, any statement by a reputable cancer organization even talking about the merits of RECAF.

BTW, when searching RECAF, all I ever find is press releases, paid hype attempting to sell stock. There is absolutely NOTHING out there discussing the merits of RECAF that is independent of the company.

I do not want something that says the test works because I know the test can detect cancer cells. I want some independent information tha the test will actually be useful in the fight against cancer
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.